Imprint Labs, a NYC-based centered analysis group (FRO) constructing forensic immunology instruments, raised $15M in philanthropic funding.
Backers included Eric and Wendy Schmidt, Convergent Analysis, Peter Reinhart, and the New York Metropolis Financial Improvement Company (NYCEDC).
The corporate intends to make use of the funds to advance its work to decode the physique’s immune reminiscence and uncover the causes of continual illnesses.
Led by CEO Beck Brachman, Imprint Labs is a forensic immunology centered analysis group (FRO) constructing experimental and machine studying instruments to determine the hidden causes of and cures for continual illnesses. The corporate is constructing instruments to reconstruct immune histories from reminiscence B cells and T cells at scale. This “forensic immunology2 strategy goals to unlock the secrets and techniques held inside reminiscence immune cells, which include an archive of all immune exposures all through an individual’s life – basically an online browser historical past of illnesses and their hidden triggers. Not like a person’s genes, the related sign saved within the immune repertoire is distributed, sparse, and always evolving, making it an order of magnitude tougher to resolve than the genome.
The corporate was incubated by Cornell Tech.
FinSMEs
15/05/2025
